Lodise et al identified risk factors for nephrotoxicity in a patient being treated with vancomycin. These factors can help to identify a patient who may benefit from interventions to reduce the risk. The authors are from Albany College of Pharmacy, Ordway Research Institute (Albany), and Albany Medical Center.
